All articles by lroy
lroy
Breakthrough Device status granted for Dthera’s Alzheimer’s treatment
The US Food and Drug Administration (FDA) has granted Breakthrough Device designation to digital therapeutic company Dthera Sciences for its development-stage product DTHR-ALZ.